Marksans Pharma and Sun Pharma voluntarily recall metformin EP News Bureau Oct 6, 2020 oth the companies are recalling metformin because it may contain N-nitrosodimethylamine (NDMA) above the acceptable intake limit.
Sun Pharma recalls metformin due to high NDMA levels EP News Bureau Sep 24, 2020 NDMA is classified as a probable human carcinogen based on results from laboratory tests
Sun Pharma launches diabetes drug in the US market Press Trust of India Feb 26, 2020 Riomet ER is the first and only US Food and Drug Administration (FDA)-approved liquid formulation of extended release metformin
